FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Watson Laboratories ZARAH¿ Drospirenone/ Ethinyl Estradiol Recall

ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3

Watson Laboratories Inc · Corona, CA

Risk level
Class II
Reported by FDA
Mar 27, 2013
Recall ID
D-205-2013
Check your lot numberHow we source this data

Summary

Watson Laboratories recalled ZARAH¿ Drospirenone/ Ethinyl Estradiol starting Feb 13, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-205-2013 on Mar 27, 2013. Reason: Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) . Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .

Product description

ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton; NDC 52544-981-28

Lot numbers, UPCs & expiration codes

Lot #s: 401536AA/401536A; 401537AA/401537/A; 401538AA/401538/A; 406985AA/406985A; 432058AA/432058A; 512685AA/512685A

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-205-2013
Classification
Class II
Status
Terminated
Recall initiated
Feb 13, 2013
FDA report date
Mar 27, 2013
Quantity
136,720 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Watson Laboratories Inc

Original FDA data

Every field from FDA enforcement report D-205-2013, exactly as published.

Show all FDA fields
City
Corona
State
CA
Status
Terminated
Country
United States
Event ID
64358
Address
311 Bonnie Cir
Code information
Lot #s: 401536AA/401536A; 401537AA/401537/A; 401538AA/401538/A; 406985AA/406985A; 432058AA/432058A; 512685AA/512685A
Postal code
92880-2882
Report date
Mar 27, 2013
Product type
Drugs
Recall number
D-205-2013
Classification
Class II
Recalling firm
Watson Laboratories Inc
Product quantity
136,720 cartons
Termination date
Jan 31, 2014
Reason for recall
Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .
Voluntary / mandated
Voluntary: Firm initiated
Product description
ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton; NDC 52544-981-28
Distribution pattern
Nationwide
Recall initiation date
Feb 13, 2013
Initial firm notification
Letter
Center classification date
Mar 19, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-205-2013, published Mar 27, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls